Seeing Is Believing
Currently out of the existing stock ratings of Christopher Pasquale, 7 are a HOLD (28%), 18 are a BUY (72%).
Analyst Christopher Pasquale works with a stock forecast success ratio of 59.85% fulfilled within 136.36 days on average.
Christopher Pasquale’s has documented 45 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PRCT, Procept Biorobotics Corp at 09-Mar-2022.
Analyst best performing recommendations are on PRCT (PROCEPT BIOROBOTICS CORP).
The best stock recommendation documented was for PRCT (PROCEPT BIOROBOTICS CORP) at 10/11/2021. The price target of $45 was fulfilled within 2 days with a profit of $3.45 (8.3%) receiving and performance score of 41.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
151
$11.06 (7.90%)
147
2 months 28 days ago
17/21 (80.95%)
$23.88 (18.79%)
139
Buy
150
$10.06 (7.19%)
160
4 months 1 days ago
18/26 (69.23%)
$26.71 (21.66%)
121
Buy
136
$-3.94 (-2.82%)
128
4 months 7 days ago
8/9 (88.89%)
$13.71 (11.21%)
82
Buy
100
$-39.94 (-28.54%)
17.75
6 months 3 days ago
4/4 (100%)
$19.51 (24.24%)
497
Buy
145
$5.06 (3.62%)
155
6 months 10 days ago
10/12 (83.33%)
$59.79 (70.17%)
216
What Year was the first public recommendation made by Christopher Pasquale?